Literature DB >> 1712337

Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506.

A Francavilla1, T E Starzl, M Barone, Q H Zeng, K A Porter, A Zeevi, P M Markus, M R van den Brink, S Todo.   

Abstract

Evidence could not be found of immune modulation of liver regeneration. The powerful immunosuppressive drug FK 506, which augments the response after partial hepatectomy in normal rats, had the same effect in T cell-deficient nude rats. The cytotoxicity of natural killer cells in treated nude rats was not significantly changed by FK 506 therapy. However, the serum of FK 506-treated nude rats increased hepatocyte proliferation when added to third-party hepatocyte cultures, suggesting that FK 506 had induced a serum growth factor in the nude rats or had suppressed an inhibitory factor. A hypothesis was advanced that FK 506 (and cyclosporine) affects hepatic growth by nonimmunological pathways.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712337      PMCID: PMC2976619          DOI: 10.1002/hep.1840140123

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  20 in total

1.  FK 506 as a growth control factor.

Authors:  A Francavilla; M Barone; T E Starzl; A Zeevi; C Scotti; G Carrieri; V Mazzaferro; J Prelich; S Todo; G Eiras
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

Review 2.  Chemistry and biology of the immunophilins and their immunosuppressive ligands.

Authors:  S L Schreiber
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

3.  Hepatotrophic effects of FK506 in dogs.

Authors:  T E Starzl; K A Porter; V Mazzaferro; S Todo; J Fung; A Francavilla
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

4.  FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

Authors:  T Kino; H Hatanaka; S Miyata; N Inamura; M Nishiyama; T Yajima; T Goto; M Okuhara; M Kohsaka; H Aoki
Journal:  J Antibiot (Tokyo)       Date:  1987-09       Impact factor: 2.649

5.  Cyclosporine A augments the regenerative response after partial hepatectomy in the rat.

Authors:  D Kahn; H S Lai; H Romovacek; L Makowka; D Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

6.  Cyclosporin A stimulates proliferation of the liver cells after partial hepatectomy in rats.

Authors:  Y I Kim; R Y Calne; N Nagasue
Journal:  Surg Gynecol Obstet       Date:  1988-04

7.  Augmentation of rat liver regeneration by FK 506 compared with cyclosporin.

Authors:  A Francavilla; M Barone; S Todo; Q Zeng; K A Porter; T E Starzl
Journal:  Lancet       Date:  1989-11-25       Impact factor: 79.321

8.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.

Authors:  J J Siekierka; S H Hung; M Poe; C S Lin; N H Sigal
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

9.  The hepatotropic influence of cyclosporine.

Authors:  V Mazzaferro; K A Porter; C L Scotti-Foglieni; R Venkataramanan; L Makowka; L Rossaro; A Francavilla; S Todo; D H Van Thiel; T E Starzl
Journal:  Surgery       Date:  1990-05       Impact factor: 3.982

10.  The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase.

Authors:  G Fischer; H Bang
Journal:  Biochim Biophys Acta       Date:  1985-03-22
View more
  20 in total

1.  Inhibition of liver, kidney, and intestine regeneration by rapamycin.

Authors:  A Francavilla; T E Starzl; C Scotti; G Carrieri; A Azzarone; Q H Zeng; K A Porter; S L Schreiber
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

2.  Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1.

Authors:  A Azzarone; A Francavilla; G Carrieri; A Gasbarrini; C Scotti-Foglieni; S Fagiuoli; U Cillo; Q H Zeng; T E Starzl
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

Review 3.  The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo.

Authors:  A Francavilla; T E Starzl; B Carr; A Azzarone; G Carrieri; Q H Zeng; K A Porter
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 4.  Hepatic regeneration and growth factors.

Authors:  A Francavilla; L Polimeno; M Barone; A Azzarone; T E Starzl
Journal:  J Surg Oncol Suppl       Date:  1993

5.  Adverse effects of FK 506 overdosage after liver transplantation.

Authors:  M Alessiani; U Cillo; J J Fung; W Irish; K Abu-Elmagd; A Jain; S Takaya; D Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

Review 6.  Immunological aspects of liver cell transplantation.

Authors:  Felix Oldhafer; Michael Bock; Christine S Falk; Florian W R Vondran
Journal:  World J Transplant       Date:  2016-03-24

7.  Hepatic growth effects of methylprednisolone, azathioprine, mycophenolic acid, and mizoribine.

Authors:  A Azzarone; A Francavilla; Q H Zeng; T E Starz
Journal:  Transplantation       Date:  1993-07       Impact factor: 4.939

8.  Effects of tacrolimus and insulin in a liver regeneration model in growing animals with portal vein stenosis: immunohistochemical and molecular studies.

Authors:  Ariane Nadia Backes; Ana Cristina Aoun Tannuri; Fabiane Neiva Backes; Amadeu Jose Rodrigues Queiroz; Maria Cecília Mendonça Coelho; Elenice Lima da Silva; Evandro Sobroza de Mello; Uenis Tannuri
Journal:  Pediatr Surg Int       Date:  2014-04       Impact factor: 1.827

Review 9.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Effect of cyclosporine on liver regeneration after orthotopic reduced-size hepatic transplantation in the rat.

Authors:  N Kikuchi; Y Yamaguchi; K Mori; N Takata; M Goto; Y Makino; H Hamaguchi; N Hisama; M Ogawa
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.